Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Invested Capital (2018 - 2025)

Bicycle Therapeutics' Return on Invested Capital history spans 8 years, with the latest figure at 0.08% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 40.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 40.0%, while the annual FY2025 figure was 0.07%, 59.0% up from the prior year.
  • Return on Invested Capital reached 0.08% in Q4 2025 per BCYC's latest filing, up from 0.44% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.08% in Q4 2025 to a low of 0.65% in Q2 2023.
  • Average Return on Invested Capital over 5 years is 0.38%, with a median of 0.41% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: crashed -38bps in 2023, then surged 40bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.25% in 2021, then tumbled by -73bps to 0.43% in 2022, then decreased by -11bps to 0.48% in 2023, then increased by 1bps to 0.47% in 2024, then skyrocketed by 84bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Return on Invested Capital are 0.08% (Q4 2025), 0.44% (Q3 2025), and 0.37% (Q2 2025).